Learnings from clinical trials in patients with connective tissue disease-associated interstitial lung disease

被引：0
|
作者：
Jean Paul Higuero Sevilla
Areeka Memon
Monique Hinchcliff
机构：
[1] Yale School of Medicine,Department of Internal Medicine, Section of Pulmonary, Critical Care and Sleep Medicine
[2] University of Connecticut School of Medicine,Department of Internal Medicine
[3] Allergy & Immunology,Department of Internal Medicine, Section of Rheumatology
[4] Yale School of Medicine,undefined
来源：
Arthritis Research & Therapy | / 25卷
关键词：
Scleroderma; Systemic sclerosis; Interstitial lung disease; Inflammatory lung disease; Fibrotic lung disease; Connective tissue disease; Nintedanib; Pirfenidone; Tocilizumab; Rituximab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Many clinical trial results are available to inform best practices in the treatment of patients with connective tissue disease-associated interstitial lung disease (CTD-ILD).
引用
收藏
相关论文
共 50 条
  • [31] Current approach to connective tissue disease-associated interstitial lung disease
    Solomon, Joshua J.
    Chartrand, Sandra
    Fischer, Aryeh
    CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (05) : 449 - 456
  • [32] Sleep Disorders Among Patients with Connective Tissue Disease-associated Interstitial Lung Disease
    Mruthyunjaya, Prakashini
    Ghosh, Anushka
    Meka, Surya Teja
    Subhankar, Saswat
    Akkiraju, Yashaswi Ranga Bharadwaj
    Maikap, Debashis
    Singh, Pratima
    Padhan, Prasanta
    INDIAN JOURNAL OF RHEUMATOLOGY, 2025, 20 (01) : 41 - 47
  • [33] Rituximab in autoimmune connective tissue disease-associated interstitial lung disease
    Sharp, Charles
    McCabe, Melanie
    Dodds, Nick
    Edey, Anthony
    Mayers, Lloyd
    Adamali, Huzaifa
    Millar, Ann B.
    Gunawardena, Harsha
    RHEUMATOLOGY, 2016, 55 (07) : 1318 - 1324
  • [34] Connective Tissue Disease-Associated Interstitial Lung Disease: A Focused Review
    Solomon, Joshua J.
    Fischer, Aryeh
    JOURNAL OF INTENSIVE CARE MEDICINE, 2015, 30 (07) : 392 - 400
  • [35] Genetics and pathogenesis of connective tissue disease-associated interstitial lung disease
    Kumar, Sharath
    INDIAN JOURNAL OF RHEUMATOLOGY, 2021, 16 (05) : 29 - 38
  • [36] Connective Tissue Disease-Associated Interstitial Lung Disease Evaluation and Management
    Antin-Ozerkis, Danielle
    Hinchcliff, Monique
    CLINICS IN CHEST MEDICINE, 2019, 40 (03) : 617 - +
  • [37] Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease
    Oldham, Justin M.
    Lee, Cathryn
    Valenzi, Eleanor
    Witt, Leah J.
    Adegunsoye, Ayodeji
    Hsu, Scully
    Chen, Lena
    Montner, Steven
    Chung, Jonathan H.
    Noth, Imre
    Vij, Rekha
    Strek, Mary E.
    RESPIRATORY MEDICINE, 2016, 121 : 117 - 122
  • [38] Lung Ultrasound in Patients with Connective Tissue Disease-associated Interstitial Lung Disease; Utility of Single Evaluation in Clinical Practice
    Watanabe, Shinji
    Yomono, Keina
    Suzuki, Mikito
    Sasaki, Nobuhito
    Gono, Takahisa
    Kuwana, Masataka
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2450 - 2453
  • [39] Lung Cancer In Connective Tissue Disease-Associated Interstitial Lung Disease: Clinical Features And Impact On Outcome
    Watanabe, S.
    Waseda, Y.
    Takato, H.
    Matsunuma, R.
    Saeki, K.
    Hara, J.
    Sone, T.
    Abo, M.
    Kimura, H.
    Kasahara, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [40] Lung cancer in connective tissue disease-associated interstitial lung disease: clinical features and impact on outcomes
    Watanabe, Satoshi
    Saeki, Keigo
    Waseda, Yuko
    Murata, Akari
    Takato, Hazuki
    Ichikawa, Yukari
    Yasui, Masahide
    Kimura, Hideharu
    Hamaguchi, Yasuhito
    Matsushita, Takashi
    Yamada, Kazunori
    Kawano, Mitsuhiro
    Furuichi, Kengo
    Wada, Takashi
    Kasahara, Kazuo
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 799 - 807
12345